Quoin Pharmaceuticals, Ltd.
QNRX
$6.75
$0.152.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.64% | -19.04% | 15.18% | -13.53% | -6.39% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -2.72% | -1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.53% | -14.35% | 38.13% | 5.65% | 52.62% |
| Change in Net Operating Assets | -107.35% | 70.62% | -152.72% | 147.13% | -410.97% |
| Cash from Operations | -2.62% | -8.58% | -39.93% | 55.50% | -143.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -222.20% | -17.57% | 170.65% | -268.90% | 330,400.00% |
| Cash from Investing | -222.20% | -17.57% | 170.65% | -268.90% | 330,400.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 45.45% |
| Issuance of Common Stock | 6,071,300.00% | -99.27% | -99.75% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,050.23% | -9.98% | -102.56% | 3,020.32% | 33.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.52% | -73.15% | 278.19% | 25.52% | 52.23% |